Tablo Announces $76.5M Investment.
*Bringing its total to $185.5M, Outset Medical announces a new investment from T. Row Price Associates. The Tablo machine is rethinking HD technology from the ground up. A minifridge-sized unit can purify tap water, send and receive data, and even clear air bubbles from the dialyzer and bloodlines.
Read the full article » | Posted 06-12-2017
Related Articles
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026
- Meet the Dutch Neokidney: a New Suitcase Hemodialysis Machine Posted 01-16-2026
- Watch an AKF Webinar on Advancements in Home Dialysis Posted 12-17-2025

